North Logan, UT, United States of America

Jon Y Takemoto

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 2.2

ph-index = 2

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 1998-2024

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Innovations of Jon Y Takemoto

Introduction

Jon Y Takemoto is a notable inventor based in North Logan, Utah. He has made significant contributions to the field of bioactive compounds, particularly in the development of novel treatments for fungal and bacterial diseases. With a total of 10 patents to his name, Takemoto's work is recognized for its potential impact on medical science.

Latest Patents

Among his latest patents are the "Amphiphilic kanamycin compositions and methods," which focus on novel bioactive amphiphilic kanamycin compounds. These compounds are designed to treat and prevent various fungal and bacterial diseases. The invention includes methods of synthesizing and utilizing these compounds effectively. Another significant patent is the "Aminoglycoside and azole compositions and methods," which introduces a novel fungicidal compound that includes an aminoglycoside analog. This compound exhibits improved antifungal activity while maintaining minimal antibacterial properties, making it a valuable addition to antifungal treatments.

Career Highlights

Jon Y Takemoto is affiliated with Utah State University, where he continues to engage in research and development. His work has garnered attention for its innovative approach to addressing complex medical challenges.

Collaborations

Takemoto has collaborated with notable colleagues, including Dong Chen and Cheng-wei Tom Chang, enhancing the scope and impact of his research.

Conclusion

Jon Y Takemoto's contributions to the field of bioactive compounds demonstrate his commitment to innovation in medical science. His patents reflect a dedication to developing effective treatments for fungal and bacterial diseases, showcasing the importance of his work in the ongoing fight against these health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…